In an effort to increase the likelihood to detect diverting molecular features of distinct tumor areas with either oligodendroglial or astrocytic morphology we selected LOH1p/19q- and TP53- mutational analyses, as was done in similar previous studies [30], [31]. The gene discussed is TP53; the disease is neoplasm.